S. 727 · 118th Congress (2023–2025)
Insulin for All Act of 2023
This bill caps the manufacturer price of insulin at $20 per 1,000 units.
Show official title
A bill to limit the price charged by manufacturers for insulin.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 727’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Bernard Sanders (I-VT)
- Cosponsors
5 cosponsors
2 original · 3 later
- Sen. Edward J. Markey (D-MA)· Original · Mar 9, 2023
- Sen. Jeff Merkley (D-OR)· Original · Mar 9, 2023
- Sen. Peter Welch (D-VT)· Later · Mar 14, 2023
- Sen. Elizabeth Warren (D-MA)· Later · Mar 14, 2023
- Sen. Amy Klobuchar (D-MN)· Later · Mar 16, 2023
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Insulin for All Act of 2023
Display title, Short title · Introduced in Senate
A bill to limit the price charged by manufacturers for insulin.
Official title · Introduced in Senate